Certain identified information has been excluded from the exhibit because it is both (i) not material and (ii) the type of information that the registrant treats as private or confidential. Double asterisks denote omissions.] SUBLEASE BETWEEN ZUORA,...Lease Agreement • May 1st, 2024 • Corcept Therapeutics Inc • Pharmaceutical preparations • California
WE HEREBY ESTABLISH OUR IRREVOCABLE STANDBY LETTER OF CREDIT NO. SVBSF______ IN YOUR FAVOR AVAILABLE BY PAYMENT AGAINST YOUR PRESENTATION TO US, AT THE BANK’S OFFICE (AS DEFINED BELOW), OF THE FOLLOWING DOCUMENT:
NINTH AMENDMENT TO LEASELease • May 1st, 2024 • Corcept Therapeutics Inc • Pharmaceutical preparations
THIS NINTH AMENDMENT TO LEASE (the "Ninth Amendment") is made and entered into as of March 19, 2024, by and between Exponent Realty, LLC, a Delaware limited liability company ("Landlord"), and Corcept Therapeutics Incorporated, a Delaware corporation (“Tenant”).
AMENDMENT NO. 3 TO DISTRIBUTION SERVICES AGREEMENTDistribution Services Agreement • May 1st, 2024 • Corcept Therapeutics Inc • Pharmaceutical preparations • Delaware
THIS AMENDMENT NO. 3 TO THE DISTRIBUTION SERVICES AGREEMENT (“Agreement”) between Corcept Therapeutics Incorporated, located at 149 Commonwealth Drive, Menlo Park, CA 94025 ("Corcept"), and Optime Care, Inc., with its principal place of business at 4060 Wedgeway Court, Earth City, MO 63045 (“Optime”) shall be effective as of April 1, 2024 (“Effective Date”). Each of Corcept Therapeutics Incorporated and Optime Care, Inc. may be referred to herein individually as a “Party” or collectively as the “Parties.”
